GET THE REBATE

Insured patients:
Register below for your Epiduo (adapalene and benzoyl peroxide) Gel 0.1% / 2.5% Instant Advantage Card. Insured patients could pay no more than $35* for their Epiduo® Gel prescription (for one tube or pump, after primary insurance and the Epiduo Gel Instant Advantage Card).

Uninsured and cash patients:
Register below for your Epiduo Gel Instant Advantage Card, which could reduce your out-of-pocket cost for Epiduo® Gel by up to $50.

Galderma is committed to protecting and safeguarding your privacy. To better understand how we use the data you provide from this site, please read our Privacy Policy. We will not sell your information, and you will not receive anything from us that you have not agreed to receive.

**Required field

**First Name:
**Last Name:
**Address 1:
Address 2:
**City:
**State:
**ZIP Code:
**Email:
**Email Confirmation:
**Date of Birth:
    
**Gender:

** How long have you been dealing with breakouts?

** Have you seen a doctor about treatment yet?

** How do you plan to use your Epiduo® Gel rebate?

Rebates are not valid for prescriptions reimbursed under a federally funded healthcare program, including Medicare or Medicaid as well as similar state programs, including any state medical assistance programs. Offer void where prohibited by law, taxed, or restricted. Offer good in and rebates emailed to addresses in the U.S.A. only. Offer good only in the United States and D.C. Void in Massachusetts, except for prescriptions that are not reimbursed by any third-party payer. Galderma Laboratories, L.P. reserves the right to rescind, revoke, or amend this offer at any time without notice. Galderma Laboratories, L.P., its officers, directors and employees, parent, subsidiaries and related companies, are not responsible for any injury or loss whatsoever resulting from technical, hardware or software failures or malfunctions, and are not responsible for illegible, lost, late, mutilated or postage due submissions.

Track your progress

Get the mobile app

Help your teen take action

Make a plan

Get the doctor discussion guide

Download the PDF

You could pay no more than $35*
and download the Blame Biology kit

Learn more

Important Safety Information
Indication: EPIDUO® Gel is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older. Adverse Events: In controlled clinical studies, the most commonly reported adverse events (≥1%) in patients treated with EPIDUO® Gel were dry skin, contact dermatitis, application site burning, application site irritation and skin irritation. Warning/Precautions: Patients taking EPIDUO® Gel should avoid exposure to sunlight and sunlamps and wear sunscreen when sun exposure cannot be avoided. Erythema, scaling, dryness, stinging/burning, irritant and allergic contact dermatitis may occur with use of EPIDUO® Gel and may necessitate discontinuation.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

* Insured patients could pay no more than $35 for their Epiduo® Gel prescription (for one tube or pump, after primary insurance and the Epiduo Gel Instant Advantage Card). Restrictions may apply.

©2012 Galderma Laboratories, L.P. United States, All Rights Reserved. All trademarks are the property of their respective owners. This site intended for U.S. audiences only. Information in this website is not intended as medical advice. Talk to your doctor about medical concerns.

Important Safety Information

Close

Indication: EPIDUO® Gel is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older. Adverse Events: In controlled clinical studies, the most commonly reported adverse events (≥1%) in patients treated with EPIDUO® Gel were dry skin, contact dermatitis, application site burning, application site irritation and skin irritation. Warnings/Precautions: Patients taking EPIDUO® Gel should avoid exposure to sunlight and sunlamps and wear sunscreen when sun exposure cannot be avoided. Erythema, scaling, dryness, stinging/burning, irritant and allergic contact dermatitis may occur with use of EPIDUO® Gel and may necessitate discontinuation.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

TWITTER FACEBOOK EMAIL
Close

SHARE THE NEWS

All fields are required.

Your Email Address:

Your Name:

Recipient's Email Address:

Send me a copy of this email

View our Privacy Policy